Login to Your Account



Deals And M&A NEWS

HONG KONG – A deal inked between Calif.-based Ionis Pharmaceuticals Inc. and Kunshan, China-based Suzhou Ribo Life Science Co. Ltd. will ease the U.S. company's entry into the Chinese innovative drug market.

Following a string of big pharma deals dating back to 2010, Tokyo-based Peptidream Inc. inked a potential $1.15 billion multitarget discovery and optimization collaboration with Janssen Pharmaceuticals Inc. that could be its largest yet.

DUBLIN – Shares in Innocoll Holdings plc surged by more than 86 percent during pre-market trading on Nasdaq Wednesday on news of a takeover offer from Gurnet Point LP valued at up to $209 million.

More Deals And M&A Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: